sábado, 31 de julio de 2021

Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs - The Lancet Rheumatology

Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario